IRM
30
2
C
51
5
JNPR
67
2
PSA
43
3
MU
42
4
QCOM
52
4
HCP
52
7
LYB
34
16
EXC
64
4
KEY
33
3
EW
46
10
PCG
74
8
WU
28
2
TDC
55
-2
CTAS
39
3
WY
33
2
GT
41
2
NWS
58
2
CSX
39
2
TMO
56
4
IRM
30
2
C
51
5
JNPR
67
2
PSA
43
3
MU
42
4
QCOM
52
4
HCP
52
7
LYB
34
16
EXC
64
4
KEY
33
3
EW
46
10
PCG
74
8
WU
28
2
TDC
55
-2
CTAS
39
3
WY
33
2
GT
41
2
NWS
58
2
CSX
39
2
TMO
56
4
Financhill
Back

Shandong Xinhua Pharmaceutical 10K Form

Sell
10

SHNXY
Shandong Xinhua Pharmaceutical

Last Price:
$18.19
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SHNXY News And Ratings

See the #1 stock for the next 7 days that we like better than SHNXY

SHNXY Financial Statistics

Sales & Book Value

Annual Sales: $1.1B
Cash Flow: $-18.2M
Price / Cash Flow: 0
Annual Sales: $10.18
Price / Book: 1.79

Profitability

EPS (TTM): 0.89190
Net Income (TTM): $62.5M
Gross Margin: $338.1M
Return on Equity: 9.11%
Return on Assets: 5.29%

Shandong Xinhua Pharmaceutical Earnings Forecast

Key Shandong Xinhua Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 30 years for SHNXY is 29.52%.
  • The Selling, General & Administrative Expenses for SHNXY have been equal to 10.22% of Gross Profit Margin.
  • The Research & Development expenses have been 5.18% of Revenue.
  • The Interest Expense is 8.29% of Operating Income.
  • The Net Earning history of SHNXY is 6.13% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 19 years.

Shandong Xinhua Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Current Symbol: SHNXY
Website: xhzy.com

Debt

Debt-to-Equity Ratio: 0.34
Current Ratio: 1.34
Quick Ratio: 0.84

Price-to-Earnings

Trailing P/E Ratio: 17.87
Forward P/E Ratio: 0

SHNXY Technical Analysis vs Fundamental Analysis

Sell
10
Shandong Xinhua Pharmaceutical (SHNXY) is a Sell

Is Shandong Xinhua Pharmaceutical a Buy or a Sell?